TherapeuticsMD Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Aug 24 | BuyUS$7,099 | Cooper Collins | Individual | 4,094 | US$1.73 | |
21 Aug 24 | BuyUS$2,039 | Cooper Collins | Individual | 1,200 | US$1.70 |
Insider Trading Volume
Insider Buying: TXMD insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 60 | 0.00052% |
Individual Insiders | 412,889 | 3.58% |
Institutions | 1,591,840 | 13.8% |
Hedge Funds | 1,828,813 | 15.9% |
General Public | 7,698,830 | 66.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,192,191 | US$1.8m | 0% | 0.03% | |||
636,622 | US$986.2k | 18.9% | 0.08% | |||
401,937 | US$622.6k | 0% | 0.23% | |||
387,582 | US$600.4k | 0% | no data | |||
270,160 | US$418.5k | -0.73% | 0.07% | |||
131,601 | US$203.9k | -0.07% | no data | |||
125,152 | US$193.9k | -7.83% | no data | |||
121,666 | US$188.5k | 0% | no data | |||
95,477 | US$147.9k | 12.6% | no data | |||
64,966 | US$100.6k | 0% | no data | |||
62,565 | US$96.9k | 0% | no data | |||
61,853 | US$95.8k | 0% | no data | |||
52,016 | US$80.6k | 11.3% | no data | |||
34,000 | US$52.7k | -13% | no data | |||
30,100 | US$46.6k | 0% | no data | |||
27,060 | US$41.9k | 0% | no data | |||
22,470 | US$34.8k | 0% | no data | |||
20,287 | US$31.4k | 0% | no data | |||
16,457 | US$25.5k | 0% | no data | |||
14,359 | US$22.2k | 0% | no data | |||
13,562 | US$21.0k | 0% | no data | |||
12,000 | US$18.6k | 0% | no data | |||
9,116 | US$14.1k | 16.7% | no data | |||
8,289 | US$12.8k | 0% | no data | |||
7,060 | US$10.9k | 0% | no data |